Carl Zeiss Meditec AG
AFX
ISIN DE0005313704 / Valor 1055489
Carl Zeiss Meditec AG
UMushroom community rating:
About company
Carl Zeiss Meditec AG is a global medical technology company specializing in providing products and workflow solutions for the diagnosis and treatment of eye diseases. In addition to offering complete solutions for visualizing minimally invasive surgical treatments in various medical fields, including neurosurgery, ENT, spine, pathology, oncology, and dentistry, the company is committed to driving progress, efficiency, and access to healthcare technology. With a focus on supporting doctors in improving their patients' quality of life, Carl Zeiss Meditec AG has established itself as a trusted partner for healthcare professionals worldwide.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (23.05.2024):
Revenue Growth
In the first half of the fiscal year 2023/24, Carl Zeiss Meditec AG reported a significant increase in revenue, continuing its growth trajectory from previous periods.
Profitability
Carl Zeiss Meditec AG's profitability metrics for the 6M 2023/24 period showed robust performance, with net income and EBIT margins improving year-over-year.
Research and Development
Investment in research and development remained a priority for Carl Zeiss Meditec AG in the 6M 2023/24, reflecting the company's commitment to innovation and maintaining its competitive edge in medical technology.
Dividend Announcement
For the fiscal period 6M 2023/24, Carl Zeiss Meditec AG announced a stable dividend, underlining its consistent return to shareholders amidst ongoing business growth.
Future Outlook
Carl Zeiss Meditec AG provided a positive outlook for the upcoming quarters, projecting continued revenue growth and market expansion based on current trends and order intakes.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
5336 M
Market cap (USD)
171,864
Daily traded volume (Shares)
57 / 54.45
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Luba Schoenig
Tonia Zimmermann
Laura Bischofberger
EQUITIES OF THE SAME SECTOR
